Nihon Kohden America, Inc. Introduces Comprehensive Surveillance for Opioid Drip Patients
10/11/2012 10:17:05 AM
FOOTHILL RANCH, Calif.--(BUSINESS WIRE)--Nihon Kohden America, a market leader in patient monitoring innovation, has evolved its award-winning Prefense — Early Detection and Notification System to enable hospitals to monitor at-risk, post-surgical patients who are on opioid drips. To achieve this advancement, Nihon Kohden America combined its Cap-STAT mainstream CO2 monitoring technology for intubated and non-intubated patients with its newest Prefense system to enable hospitals to monitor opioid-drip patients for end tidal CO2 (EtCO2), oxygen saturation (SpO2), respiration rate, heart rate and noninvasive blood pressure. This inclusion of EtC02 monitoring to Prefense is the next logical evolution of Nihon Kohden America’s innovative Defensive Monitoring™ system.
comments powered by